Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID L OLIVER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1164404455
CMS profile
623992
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$282.42

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $282.42 6

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $98.06 3
IRONWOOD PHARMACEUTICALS, INC $97.87 1
Esperion Therapeutics, Inc. $71.44 1
Smith+Nephew, Inc. $15.05 1

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID L OLIVER

NPI 1164404455 · CMS profile ID 623992

Allopathic & Osteopathic Physicians / Family Medicine

OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164404455?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID L OLIVER, NPI 1164404455, CMS profile ID 623992. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164404455?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). DAVID L OLIVER, NPI 1164404455, CMS profile ID 623992. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164404455?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
DAVID L OLIVER, NPI 1164404455, CMS profile ID 623992, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1164404455?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $282.42 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Esperion Therapeutics, Inc. $71.4410/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737230045 CMS
Lilly USA, LLC $76.6103/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728385367 CMS
Lilly USA, LLC $5.3603/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728394699 CMS
Lilly USA, LLC $16.0903/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728405821 CMS
Smith+Nephew, Inc. $15.0502/07/2020 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 750123143 CMS
IRONWOOD PHARMACEUTICALS, INC $97.8702/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749780691 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $405.23 5
PY2020 $282.42 6
PY2021 $509.12 6
PY2022 $770.26 8
PY2023 $290.27 6
PY2024 $2,305.91 23
PY2025 $352.28 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,288,478.03 35
PY2024 Recipient $48,730.50 2
PY2024 Principal investigator $760,191.54 106
PY2023 Recipient $795.01 2
PY2023 Principal investigator $798,688.88 48
PY2022 Recipient $274.00 1
PY2022 Principal investigator $738,187.49 166
PY2021 Principal investigator $437,882.52 38
PY2020 Recipient $193,202.48 6
PY2020 Principal investigator $298,634.23 42
PY2019 Principal investigator $211,648.73 76

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

167 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $47,976.89 12/22/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038531
Principal investigator 1 Novo Nordisk AS $3,000.00 11/30/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896977887
Principal investigator 1 Novo Nordisk AS $3,000.00 11/30/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306891
Principal investigator 1 Eli Lilly and Company $1,208.00 11/17/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917813473
Principal investigator 1 Eli Lilly and Company $1,208.00 11/17/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3857210 FOR THE TREATMENT OF CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 917819427
Principal investigator 1 Eli Lilly and Company $1,208.00 11/17/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917819639
Principal investigator 1 Novo Nordisk AS $8,000.00 10/24/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897057771
Principal investigator 1 Novo Nordisk AS $8,000.00 10/24/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297563
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896934071
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896934075
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896934079
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896934083
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896977840
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896978039
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896978087
Principal investigator 1 Novo Nordisk AS $7.82 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896996758
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 896997343
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897057774
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897057779
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897066781
Principal investigator 1 Novo Nordisk AS $6.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897066785
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897086995
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897087112
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897089183
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897089189
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897093721
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897093725
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897093729
Principal investigator 1 Novo Nordisk AS $40.00 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897094543
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897094547
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897094551
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134473
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134655
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134659
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134663
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134667
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897134671
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897158699
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897158703
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897158709
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897158712
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897158721
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897159057
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176103
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176733
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176763
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176767
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176771
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176775
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176779
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176859
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897176863
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897194325
Principal investigator 1 Novo Nordisk AS $39.90 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897200949
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897202047
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897202533
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897232411
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897232415
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897232419
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897232423
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234681
Principal investigator 1 Novo Nordisk AS $5.70 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234729
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234733
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234737
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234749
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234753
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234757
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234761
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234765
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897234769
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897247493
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897247497
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897247501
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897247505
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897248099
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897248103
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897248107
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257245
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257249
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257253
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257257
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257261
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897257265
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897258609
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897259566
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279491
Principal investigator 1 Novo Nordisk AS $1.98 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279551
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279575
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279579
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279583
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279587
Principal investigator 1 Novo Nordisk AS $8.00 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279591
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279601
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279605
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279613
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279655
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279673
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279797
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279801
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279813
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279817
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279821
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279825
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279829
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279833
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279905
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279909
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279913
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279917
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897279921
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297143
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297331
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297335
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297543
Principal investigator 1 Novo Nordisk AS $9.74 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297547
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297551
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297555
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297559
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297567
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297571
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897297575
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298511
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298515
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298519
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298523
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298527
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298531
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298535
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298539
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298543
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298547
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298551
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897298725
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306819
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306871
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306873
Principal investigator 1 Novo Nordisk AS $11.38 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306877
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306879
Principal investigator 1 Novo Nordisk AS $5.50 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306881
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306883
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306885
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306887
Principal investigator 1 Novo Nordisk AS $3.05 10/14/2022 Non-covered Recipient Entity
RENSTAR, INC
NN9535-4801 No dispute reported 06/30/2026 897306889
Principal investigator 1 GlaxoSmithKline, LLC. $241.45 08/23/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038583
Principal investigator 1 GlaxoSmithKline, LLC. $360.57 08/18/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038501
Principal investigator 1 GlaxoSmithKline, LLC. $1,920.12 08/18/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038553
Principal investigator 1 GlaxoSmithKline, LLC. $2,349.36 08/18/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038573
Principal investigator 1 GlaxoSmithKline, LLC. $46,135.46 07/19/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038541
Principal investigator 1 GlaxoSmithKline, LLC. $3,283.79 06/21/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038511
Principal investigator 1 Eli Lilly and Company $4,926.00 06/07/2022 Non-covered Recipient Entity
RENSTAR INC
MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917839781
Principal investigator 1 Eli Lilly and Company $4,816.00 06/02/2022 Non-covered Recipient Entity
RENSTAR INC
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3016859 FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN No dispute reported 06/30/2026 917836727
Principal investigator 1 Eli Lilly and Company $43,871.00 05/24/2022 Non-covered Recipient Entity
RENSTAR INC
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917838767
Principal investigator 1 GlaxoSmithKline, LLC. $8,663.25 05/24/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038521
Principal investigator 1 GlaxoSmithKline, LLC. $20,528.52 05/12/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038491
Principal investigator 1 GlaxoSmithKline, LLC. $346,015.41 05/03/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH INC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 944038563
Recipient Eli Lilly and Company $274.00 04/29/2022 Covered Recipient Physician RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN No dispute reported 06/30/2026 917809883
Principal investigator 1 Eli Lilly and Company $26,964.00 04/12/2022 Non-covered Recipient Entity
RENSTAR INC
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917839769
Principal investigator 1 Eli Lilly and Company $936.00 03/28/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN No dispute reported 06/30/2026 917813465
Principal investigator 1 Eli Lilly and Company $836.00 03/28/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917814911
Principal investigator 1 Eli Lilly and Company $730.00 02/23/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917821425
Principal investigator 1 Eli Lilly and Company $154.00 02/23/2022 Non-covered Recipient Entity
RENSTAR INC
RANDOMIZED PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL TO EVALUATE LY3526318 FOR THE TREATMENT OF CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 917841465
Principal investigator 1 Eli Lilly and Company $927.00 01/31/2022 Non-covered Recipient Entity
RENSTAR MEDICAL RESEARCH
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN No dispute reported 06/30/2026 917829613
Principal investigator 1 Eli Lilly Export S.A. Puerto Rico Branch $22.00 01/26/2022 Covered Recipient Teaching Hospital
UNIVERSITY OF ALABAMA HOSPITAL
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3016859 FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN No dispute reported 06/30/2026 917819641
Principal investigator 1 Eli Lilly and Company $1,249.00 01/26/2022 Non-covered Recipient Entity
ONCOLOGY CONSULTANTS PA
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917834035
Principal investigator 1 Eli Lilly and Company $604.00 01/17/2022 Non-covered Recipient Entity
RENSTAR INC
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN No dispute reported 06/30/2026 917839763
Principal investigator 1 Eli Lilly and Company $114.00 01/04/2022 Non-covered Recipient Entity
RENSTAR INC
A MASTER PROTOCOL FOR RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL TRIALS OF MULTIPLE INTERVENTIONS FOR THE TREATMENT OF CHRONIC PAIN No dispute reported 06/30/2026 917837777
Principal investigator 1 Eli Lilly and Company $147,976.00 01/03/2022 Non-covered Recipient Entity
RENSTAR INC
RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN No dispute reported 06/30/2026 917832277